Agenda Topics- 3D-Cell Based Models
- Antibodies for New Targets
- Antibody Drug Conjugates (ADCs)
- Antibody Screening
- Humanized Single Domain Antibodies for Research and Therapeutic Applications
- iPSC-derived Cells for Toxicity Testing & Screening
- Monoclonal Antibodies
- Scale Up and Quality Control
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Toxicity Screening
- Targeting Ion Channels with Biologics
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyNicholas Hannan, Assistant Professor, University of Nottingham Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison Alice Pébay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge Davide Danovi, Director, Cell Phenotyping Platform, Kings College London Peter O'Brien, Head of Clinical Pathology, University College Dublin Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star E. Sally Ward, Professor, Texas A&M University Health Science Center Hugh Byrne, Professor, Dublin Institute of Technology Wing Chang, R&D Director, STEMCELL Technologies Win-Yan Chan, Research Scientist, UCB Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC) Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV Tristan Vaughan, Vice President, R&D, Antibody Discovery and Protein Engineering, MedImmune Ltd
|